Potassium Ion

Potassium Ion

SCHEMBL217908

O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)S(=O)(=O)[O-].[K+].[K+]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CA2 P00918 4/20 0.40
CA1 P00915 3/20 0.40
MMP1 P03956 2/20 0.40
MMP2 P08253 2/20 0.40
MMP9 P14780 2/20 0.40
MMP8 P22894 2/20 0.40
MMP13 P45452 2/20 0.40
F2 P00734 2/20 0.31
PRSS1 P07477 2/20 0.31
PRSS2 P07478 2/20 0.31
PRSS3 P35030 2/20 0.31
CA7 P43166 1/20 0.30
CA13 Q8N1Q1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL2500523 0.97 CA2 (0.42) CA2CA1MMP1MMP2MMP9
Potassium Ion SCHEMBL2499167 0.93 CA2 (0.35) CA2CA1MMP1MMP2MMP9
Lithium Ion SCHEMBL3745424 0.93 CA2 (0.40) CA2CA1MMP1MMP2MMP9
SCHEMBL2499938 0.93 CA2 (0.42) CA2CA1MMP1MMP2MMP9
Potassium Ion SCHEMBL126340 0.91 CA2 (0.52) CA2CA1MMP1MMP2MMP9
Potassium Ion SCHEMBL29395213 0.90 CA1 (0.33) CA2CA1MMP1MMP2MMP9
Potassium Ion SCHEMBL9855988 0.89 CA2 (0.34) CA2CA1MMP1MMP2MMP9
Potassium Ion SCHEMBL2354990 0.89 CA2 (0.52) CA2CA1MMP1MMP2MMP9
Potassium Ion SCHEMBL4443223 0.89 CA2 (0.54) CA2CA1MMP1MMP2MMP9
Potassium Ion SCHEMBL4056625 0.89 CA2 (0.54) CA2CA1MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4479476-A1 FLAME-RETARDANT POLYCARBONATE COMPOSITION Covestro Deutschland AG (DE) 2024-12-25 EP disclosed
CN-118696093-A Flame retardant polycarbonate compositions 科思创德国股份有限公司 2024-09-24 CN disclosed
EP-4204492-B1 HYDROLYSIS-RESISTANT POLYCARBONATE COMPOSITION COVESTRO DEUTSCHLAND AG (DE) 2024-06-26 EP disclosed
US-20230312918-A1 Hydrolysis-Resistant Polycarbonate Composition COVESTRO DEUTSCHLAND AG (DE) 2023-10-05 US disclosed
WO-2023156339-A1 FLAME-RETARDANT POLYCARBONATE COMPOSITION COVESTRO DEUTSCHLAND AG (DE) 2023-08-24 WO disclosed
EP-4230697-A1 HYDROLYSIS-RESISTANT POLYCARBONATE COMPOSITION Covestro Deutschland AG (DE) 2023-08-23 EP disclosed
CN-116096818-A Hydrolysis-resistant polycarbonate compositions 科思创德国股份有限公司 2023-05-09 CN disclosed
WO-2022043424-A1 HYDROLYSIS-RESISTANT POLYCARBONATE COMPOSITION COVESTRO DEUTSCHLAND AG (DE) 2022-03-03 WO disclosed
EP-2610308-B1 USE OF POLYCARBOSILANE AS DISPERSANT FOR FLUOROPOLYMERS IN POLYCARBONATE RESINS MITSUBISHI ENG PLASTICS CORP (JP) 2020-07-15 EP disclosed
EP-2743314-B1 POLYCARBONATE RESIN COMPOSITION AND MOLDED OBJECT THEREOF MITSUBISHI ENG PLASTICS CORP (JP) 2020-02-26 EP disclosed
US-7223891-B2 Solid-phase preparation of [18F] fluorohaloalkanes HAMMERSMITH IMANET LTD. (GB) 2007-05-29 US disclosed
EP-1572602-B1 SOLID-PHASE PREPARATION OF [18F] FLUOROHALOALKANES HAMMERSMITH IMANET LTD (GB) 2007-05-09 EP disclosed
WO-2007007175-A2 PHOTOACTIVE COMPOUNDS AZ ELECTRONIC MATERIAL USA CORP. (DE) 2007-01-18 WO disclosed
US-20070015084-A1 Iodonium or sulfonium di-(tetrafluoroethyl sulfonate) ether acid generators; imaging negative and positive patterns in semiconductors and photoresists; microlithography; high photosensitivity MERCK PATENT GMBH (DE) 2007-01-18 US disclosed
US-20060069294-A1 Solid-phase preparation of [18f] fluorohaloalkanes HAMMERSMITH IMANET LLIMITED (GB) 2006-03-30 US disclosed
EP-1572602-A1 SOLID-PHASE PREPARATION OF [18F] FLUOROHALOALKANES Hammersmith Imanet Limited (GB) 2005-09-14 EP disclosed
US-20040236085-A1 Solid-phase nucleophilic fluorination GE HEALTHCARE LIMITED (GB) 2004-11-25 US disclosed
WO-2004056726-A1 SOLID-PHASE PREPARATION OF [18F]FLUOROHALOALKANES HAMMERSMITH IMANET LIMITED (GB) 2004-07-08 WO disclosed
EP-1418950-A1 SOLID-PHASE NUCLEOPHILIC FLUORINATION Amersham plc (GB) 2004-05-19 EP disclosed
WO-2003002157-A1 SOLID-PHASE NUCLEOPHILIC FLUORINATION AMERSHAM PLC (GB) 2003-01-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040236085-A1 Solid-phase nucleophilic fluorination NAA15, SAMHD1, TMEM14C CA2 3657/4885CA1 1317/4885MMP1 2331/4885
US-20060069294-A1 Solid-phase preparation of [18f] fluorohaloalkanes SLCO2A1, SLCO2B1, FES CA2 1761/4885CA1 371/4885MMP1 791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.